FIELD: chemistry.
SUBSTANCE: invention relates to a fused heterocyclic compound of formula (I), (II), (III), a method for its preparation, its use and a pharmaceutical composition based thereon.
.
EFFECT: obtaining novel compounds that have the function of selective inhibition of the p110δ subtype of PI3 kinase, which can be used for the manufacture of drugs for the prevention and treatment of diseases, such as cancer, immunological or inflammatory diseases.
19 cl, 3 tbl, 39 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SELECTIVE PROTEIN KINASE INHIBITORS | 2012 |
|
RU2612972C2 |
| QUINOLINE DERIVATIVES AS SMO INHIBITORS | 2015 |
|
RU2695815C2 |
| CDK4/6 INHIBITOR | 2017 |
|
RU2747311C2 |
| ISOINDOLINE COMPOUND, PRODUCTION METHOD, PHARMACEUTICAL COMPOSITION AND THEIR USE | 2019 |
|
RU2813232C2 |
| COMPOUND AS CYCLIN-DEPENDENT KINASE 9 INHIBITOR AND USE THEREOF | 2020 |
|
RU2819762C1 |
| TETRAHYDROIMIDAZO[1,5-D][1,4]OXAZEPINE DERIVATIVE | 2014 |
|
RU2659219C2 |
| PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
| NITROGEN-CONTAINING HETEROCYCLIC AROMATIC COMPOUND, METHOD FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND USE THEREOF | 2017 |
|
RU2729999C1 |
| TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DESTROYERS | 2017 |
|
RU2797244C2 |
| PYRROLO[2,1-f][1,2,4]TRIAZINE COMPOUND, METHOD FOR PRODUCTION AND USE THEREOF | 2013 |
|
RU2589053C1 |
